Abstract
Mitochondrial DNA (mtDNA) instability has been observed in different types of cancer, including colorectal, breast, and gastric cancer. The relationship between the occurrence of such alteration and the nuclear microsatellite instability (nMI) status of the neoplastic cells remains controversial. In an attempt to clarify this issue, we sequenced the first and second mtDNA hypervariable regions, and typed the mitochondrial (CA)n dinucleotide polymorphism in 69 patients with primary tumors of the central nervous system (CNS), previously screened for nMI. Tumor samples showed 27 D-loop sequence changes (39.1%) compared to the corresponding blood samples. Microsatellite homoplasmic allele mutations were detected in four cases (5.8%). We did not find significant associations of the mtDNA instability status with clinicopathological parameters including sex, age, tumor size, and duration of clinical course. Neither did we find any association between mtDNA and nuclear instabilities, indicating that, at least in CNS tumors, they respond to different DNA repair mechanisms. We have also compiled the mtDNA instabilities previously reported by other authors for several types of tumors, comparing them to mtDNA polymorphisms in human populations. Most of the tumor-associated changes are common human polymorphisms and mutational hotspots. To explain the molecular behavior of mtDNA instability in tumors, we propose a model also common to other biological situations.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aaltonen LA, Peltomäki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin J-P, Jarvinen H, Powell SM, Jen J, Hamilton SR, Petersen GM, Kinzler KW, Vogelstein B and de la Chapelle A . (1993). Science, 260, 812–816.
Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM and Howell N . (1999). Nat. Genet., 23, 147.
Bandelt H-J, Forster P and Röhl A . (1999). Mol. Biol. Evol., 16, 37–48.
Bandelt H-J, Forster P, Sykes BC and Richards MB . (1995). Genetics, 141, 743–753.
Bandelt H-J, Quintana-Murci L, Salas A and Macaulay V . (2002). Am. J. Hum. Genet., 71, 1150–1160.
Bodenteich A, Mitchell LG, Polymeropoulos MH and Merril CR . (1992). Hum. Mol. Genet., 1, 140.
Chinnery PF, Samuels DC, Elson J and Turnbull D . (2002). Lancet, 360, 1323–1325.
Coller HA, Khrapko K, Bodyak ND, Nekhaeva E, Herrero-Jimenez P and Thilly WG . (2001). Nat. Genet., 28, 147–150.
Daumas-Duport C, Scheithauer BW, O'Fallon J and Kelly P . (1988). Cancer, 62, 2152–2165.
Field JK, Kiaris H, Howard P, Vaughan ED, Spandidos DA and Jones AS . (1995). Br. J. Cancer, 71, 1065–1069.
Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, Jen J and Sidransky D . (2000). Science, 287, 2017–2019.
Forster L, Forster P, Lutz-Bonengel S, Willkomm H and Brinkmann B . (2002). Proc. Natl. Acad. Sci. USA, 99, 13950–13954.
Gall K, Pavelic J, Jadro-Santel D, Poljak M and Pavelik K . (1993). Int. J. Exp. Pathol., 74, 333–337.
Habano W, Nakamura S and Sugai T . (1998). Oncogene, 17, 1931–1937.
Habano W, Sugai T, Nakamura SI, Uesugi N, Yoshida T and Sasou S . (2000). Gastroenterology, 118, 835–841, (reply to Schwartz and Perucho. (2000). Gastroenterology, 119, 1806–1807).
Herrnstadt C, Elson JL, Fahy E, Preston G, Turnbull DM, Anderson C, Ghosh SS, Olefsky JM, Beal MF, Davis RE and Howell N . (2002). Am. J. Hum. Genet., 70, 1152–1171.
Ingman M, Kaessmann H, Pääbo S and Gyllensten U . (2000). Nature, 408, 708–713.
Ionov I, Peinado MA, Malkhosyan S, Shibata D and Perucho M . (1993). Nature, 363, 558–561.
Khrapko K, Coller HA, Andre PC, Li XC, Hanekamp JS and Thilly WG . (1997). Proc. Natl. Acad. Sci. USA, 94, 13798–13803.
Kiaris H, Spandidos DA, Jones AS, Vaughan ED and Field JK . (1995). Br. J. Cancer, 1, 123–128.
Kirches E, Michael M, Woy C, Schneider T, Warich-Kirches M, Schneider-Stock R, Winkler K, Wittig H and Dietzmann K . (1999). Genes Chromosomes Cancer, 26, 80–83.
Maca-Meyer N, González AM, Larruga JM, Flores C and Cabrera VM . (2001). BMC Genet., 2, 13.
Malyarchuk BA, Rogozin IB, Berikov VB and Derenko MV . (2002). Hum. Genet., 111, 46–53.
Máximo V, Soares P, Machado JC, Seruca R and Sobrinho-Simoes M . (2000). Gastroenterology, 119, 1808–1809.
Meyer S, Weiss G and von Haeseler A . (1999). Genetics, 152, 1103–1110.
Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, Markowitz SD, Trush MA, Kinzler KW and Vogelstein B . (1998). Nat. Genet., 20, 291–293.
Richards M and Macaulay V . (2001). Am. J. Hum. Genet., 68, 1315–1320.
Richards M, Macaulay V, Hickey E, Vega E, Sykes B, Guida V, Rengo C, Sellitto D, Cruciani F, Kivisild T, Villems R, Thomas M, Rychkov S, Rychkov O, Rychkov Y, Golge M, Dimitrov D, Hill E, Bradley D, Romano V, Cali F, Vona G, Demaine A, Papiha S, Triantaphyllidis C, Stefanescu G, Hatina J, Belledi M, Di Rienzo A, Novelletto A, Oppenheim A, Norby S, Al-Zaheri N, Santachiara–Benerecetti S, Scozari R, Torroni A and Bandelt HJ . (2000). Am. J. Hum. Genet., 67, 1251–1276.
Risinger JI, Berchuk A, Koheler MF, Watson P, Lynch HT and Boyd J . (1993). Cancer Res., 53, 5100–5103.
Salas A, Lareu MV and Carracedo A . (2001). Int. J. Legal Med., 114, 186–190.
Salas A, Richards M, De la Fé T, Lareu MV, Sobrino B, Sánchez-Diz P, Macaulay V and Carracedo A . (2002). Am. J. Hum. Genet., 71, 1082–1111.
Sobrido MJ, Rodriguez-Pereira C, Barros F, Forteza J, Carracedo A and Lema M . (2000). J. Neurol. Neurosurg. Psychiatry, 69, 369–375.
Stoneking M . (2000). Am. J. Hum. Genet., 67, 1029–1032.
Thibodeau SN, Bren G and Schaid D . (1993). Science, 260, 816–819.
Tully G, Barritt SM, Bender K, Brignon E, Capelli C, Dimo-Simonin N, Eichmann C, Ernst CM, Lambert C, Lareu MV, Ludes B, Mevag B, Parson W, Pfeiffer H, Salas A, Schneider PM and Staalstrom E . (2003). Forensic Sci. Int., submitted.
Vega A, Sobrido MJ, Ruiz-Ponte C, Barros F and Carracedo A . (2001). Cancer, 92, 2920–2926.
Yee CJ, Roodi N, Verrier CS and Parl FF . (1994). Cancer Res., 54, 1641–1644.
Acknowledgements
We are grateful to Patrick Chinnery for helpful comments on an advanced version of this manuscript. We express our appreciation to the sample donors. AS has a research contract with the University of Santiago de Compostela. VM was supported by the Wellcome Trust. This work was supported by grants from the Ministerio de Educación y Ciencia (DGCYT-P4. BIO2000-0145-P4-02), Ministerio de Sanidad (FIS 01/0024), and the Xunta de Galicia (PGIDT-01-PXI-20806-PR and PGIDIT02PXIC20804PN), and Ministerio de Sanidad y Consumo (Fondo de Investigación Sanitaria; Instituto de Salud Carlos III, PI030893; SCO/3425/2002).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vega, A., Salas, A., Gamborino, E. et al. mtDNA mutations in tumors of the central nervous system reflect the neutral evolution of mtDNA in populations. Oncogene 23, 1314–1320 (2004). https://doi.org/10.1038/sj.onc.1207214
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207214
Keywords
This article is cited by
-
Next-generation sequencing identifies novel mitochondrial variants in pituitary adenomas
Journal of Endocrinological Investigation (2019)
-
Phylogenetic and population-based approaches to mitogenome variation do not support association with male infertility
Journal of Human Genetics (2017)
-
Proteomic and Mitochondrial Genomic Analyses of Pediatric Brain Tumors
Molecular Neurobiology (2015)
-
Accumulation of mutations over the entire mitochondrial genome of breast cancer cells obtained by tissue microdissection
Breast Cancer Research and Treatment (2011)
-
Contamination and sample mix-up can best explain some patterns of mtDNA instabilities in buccal cells and oral squamous cell carcinoma
BMC Cancer (2009)